US equities
|
ANT
$96.29
▲+16.01%
NVDA
$148.66
▼-1.53%
AMD
$484.00
▼-8.70%
MU
$701.53
▼-0.53%
SPCX
$137.59
▼-4.12%
SNDK
$771.55
▼-0.60%
AMZN
$259.20
▼-3.19%
MSFT
$502.52
▼-1.13%
ANT
$96.29
▲+16.01%
NVDA
$148.66
▼-1.53%
AMD
$484.00
▼-8.70%
MU
$701.53
▼-0.53%
SPCX
$137.59
▼-4.12%
SNDK
$771.55
▼-0.60%
AMZN
$259.20
▼-3.19%
MSFT
$502.52
▼-1.13%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about J/R/ Rahn
Recent news which mentions J/R/ Rahn
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
Tickers
MNMD
Tags
J/R/ Rahn
Robert Barrow
MindMed
From
Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
December 10, 2021
Tickers
MNMD
NDAQ
Tags
J/R/ Rahn
Exclusives
Robert Barrow
From
Benzinga
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
August 31, 2021
Tickers
IPOS
MNMD
Tags
J/R/ Rahn
Exclusives
$LTC
From
Benzinga